MA57032A1 - Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica - Google Patents

Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Info

Publication number
MA57032A1
MA57032A1 MA57032A MA57032A MA57032A1 MA 57032 A1 MA57032 A1 MA 57032A1 MA 57032 A MA57032 A MA 57032A MA 57032 A MA57032 A MA 57032A MA 57032 A1 MA57032 A1 MA 57032A1
Authority
MA
Morocco
Prior art keywords
cas9
cell
beige
bacteria
crispr
Prior art date
Application number
MA57032A
Other languages
English (en)
Other versions
MA57032B2 (fr
Inventor
Timofey Aleksandrovich Nemankin
Roman Alekseevich Ivanov
Pavel Andreevich Iakovlev
Anna Konstantinovna Vladimirova
Dmitry Valentinovich Morozov
Sergey Anatolievich Lukyanov
Konstantin Viktorovich Severinov
Arina Vitalevna Anikina
Mariia Aleksandrovna Shchemeleva
Alexey Konstantinovich Misorin
Dmitry Borisovich Staroverov
Anna Valentinovna Evstrateva
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of MA57032A1 publication Critical patent/MA57032A1/fr
Publication of MA57032B2 publication Critical patent/MA57032B2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une nouvelle nucléase bactérienne du système crispr-cas9 à partir de la bactérie p. Pneumotropica, ainsi que son utilisation pour former des ruptures strictement spécifiques à deux brins dans la molécule d'adn. Cette nucléase possède des propriétés inhabituelles et peut être utilisée afin de modifier la séquence de l'adn génomique dans la cellule d'un organisme monocellulaire ou pluricellulaire il est ainsi possible d'améliorer l'universalité de systèmes disponibles crispr-cas9, ce qui permet d'utiliser différentes variantes de nucléases cas9 pour découper l'adn génomique ou plasmidique dans divers organismes et dans une grande quantité de sites spécifiques et/ou dans diverses conditions.
MA57032A 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica MA57032B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2019136164A RU2724470C1 (ru) 2019-11-11 2019-11-11 Применение cas9 белка из бактерии pasteurella pneumotropica для модификации геномной днк в клетках
PCT/RU2020/050145 WO2021096391A1 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Publications (2)

Publication Number Publication Date
MA57032A1 true MA57032A1 (fr) 2023-01-31
MA57032B2 MA57032B2 (fr) 2024-11-29

Family

ID=71136150

Family Applications (1)

Application Number Title Priority Date Filing Date
MA57032A MA57032B2 (fr) 2019-11-11 2020-07-02 Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica

Country Status (17)

Country Link
US (1) US20220403369A1 (fr)
EP (1) EP4056705A4 (fr)
JP (1) JP7708752B2 (fr)
KR (1) KR20220145324A (fr)
CN (1) CN115397995B (fr)
AU (1) AU2020384851A1 (fr)
BR (1) BR112022009148A2 (fr)
CA (1) CA3157898A1 (fr)
CL (1) CL2022001220A1 (fr)
CO (1) CO2022006156A2 (fr)
MA (1) MA57032B2 (fr)
MX (1) MX2022005685A (fr)
PE (1) PE20230035A1 (fr)
PH (1) PH12022551155A1 (fr)
RU (1) RU2724470C1 (fr)
WO (1) WO2021096391A1 (fr)
ZA (1) ZA202205208B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112020554B (zh) * 2018-02-23 2024-10-22 先锋国际良种公司 新颖cas9直系同源物
RU2734432C1 (ru) * 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
WO2021178709A1 (fr) * 2020-03-04 2021-09-10 Flagship Pioneering Innovations Vi, Llc Procédés et compositions pour moduler un génome

Also Published As

Publication number Publication date
CL2022001220A1 (es) 2023-01-06
US20220403369A1 (en) 2022-12-22
MA57032B2 (fr) 2024-11-29
CA3157898A1 (fr) 2021-05-20
WO2021096391A1 (fr) 2021-05-20
BR112022009148A2 (pt) 2023-05-02
ZA202205208B (en) 2023-04-26
EP4056705A1 (fr) 2022-09-14
EP4056705A4 (fr) 2023-12-27
RU2724470C1 (ru) 2020-06-23
JP7708752B2 (ja) 2025-07-15
PH12022551155A1 (en) 2023-10-02
PE20230035A1 (es) 2023-01-10
JP2023501524A (ja) 2023-01-18
KR20220145324A (ko) 2022-10-28
CN115397995A (zh) 2022-11-25
MX2022005685A (es) 2022-07-27
AU2020384851A1 (en) 2022-12-01
CN115397995B (zh) 2025-04-11
CO2022006156A2 (es) 2023-01-26

Similar Documents

Publication Publication Date Title
MA55390A1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de la bactérie pasteurella pneumotropica
Jarraud et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease
Bjornsson et al. Filamentous Chloroflexi (green non-sulfur bacteria) are abundant in wastewater treatment processes with biological nutrient removal
Voyich et al. The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus
Vancov et al. Amplification of soil fungal community DNA using the ITS86F and ITS4 primers
Sforza et al. Food analysis and food authentication by peptide nucleic acid (PNA)-based technologies
MA53577B1 (fr) Moyen de découpage d'adn à base de la protéine cas9 sur la base d'une bactérie à valeur biotechnologique clostridium cellulolyticum
MA53578A1 (fr) Dispositif pour découper l'adn à base de la protéine cas9 à partir de defluviimonas sp.
Freire-Benéitez et al. Candida albicans repetitive elements display epigenetic diversity and plasticity
Augagneur et al. Analysis of the CodY RNome reveals RsaD as a stress‐responsive riboregulator of overflow metabolism in Staphylococcus aureus
Hoang et al. Reconstruction of chromosome rearrangements between the two most ancestral duckweed species Spirodela polyrhiza and S. intermedia
Denver et al. Mutation rates, spectra and hotspots in mismatch repair-deficient Caenorhabditis elegans
MA57032A1 (fr) Utilisation de beige cas9 issu de bactérie pasteurella pneumotropica
Roberti et al. The Drosophila termination factor DmTTF regulates in vivo mitochondrial transcription
Farisa Banu et al. Marine bacterial DNase curtails virulence and disrupts biofilms of Candida albicans and non-albicans Candida species
Dereeper et al. Naegleria genus pangenome reveals new structural and functional insights into the versatility of these free-living amoebae
García-Laviña et al. Reference genes for real-time RT-PCR expression studies in an Antarctic Pseudomonas exposed to different temperature conditions
Latka et al. Genome sequence of a clinical isolate of dermatophyte, Trichophyton rubrum from India
MA43600A1 (fr) Anticorps trispecifique anti il-17a,il-17f et une autre molécule anti-inflammatoire
Cheng et al. Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient
Czyzewska et al. Genetic relationships and population structure of Malassezia pachydermatis strains isolated from dogs with otitis externa and healthy dogs
Boschmann et al. The frequency of the LCT*-13910C> T polymorphism associated with lactase persistence diverges among Euro-Descendant groups from Brazil
Yam et al. Elevated c-di-GMP levels and expression of the type III secretion system promote corneal infection by Pseudomonas aeruginosa
KR20170099804A (ko) 그람 양성 박테리아에 특이적으로 결합하는 dna 압타머 및 이의 용도
Yamamoto et al. Retrotransposon‐mediated restoration of Chlorella telomeres: accumulation of Zepp retrotransposons at termini of newly formed minichromosomes